Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group
โ Scribed by Weigel, Brenda; Malempati, Suman; Reid, Joel M.; Voss, Stephan D.; Cho, Steven Y.; Chen, Helen X.; Krailo, Mark; Villaluna, Doojduen; Adamson, Peter C.; Blaney, Susan M.
- Book ID
- 121704814
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 79 KB
- Volume
- 61
- Category
- Article
- ISSN
- 1545-5009
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND. Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against adult brain tumors, was investigated in children and adolescents with recurrent CNS tumors. ## METHODS. Temozolomide was ad
## Abstract ## BACKGROUND Docetaxel, which is an antitubulin agent, has demonstrable activity against murine and human tumors. The current study was designed to determine response rates to docetaxel in various strata of recurrent solid tumors of childhood and to assess toxicity in a group of patie